BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almasi S, El Hiani Y. Exploring the Therapeutic Potential of Membrane Transport Proteins: Focus on Cancer and Chemoresistance. Cancers (Basel) 2020;12:E1624. [PMID: 32575381 DOI: 10.3390/cancers12061624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Dunnick JK, Pandiri AR, Shockley KR, Herbert R, Mav D, Phadke D, Shah RR, Merrick BA. Single nucleotide polymorphism patterns associated with a cancer resistant phenotype. Exp Mol Pathol 2022;:104812. [PMID: 35872013 DOI: 10.1016/j.yexmp.2022.104812] [Reference Citation Analysis]
2 Ocio EM, Nadeem O, Schjesvold F, Gay F, Touzeau C, Dimopoulos MA, Richardson PG, Mateos MV. Melflufen for the treatment of multiple myeloma. Expert Rev Clin Pharmacol 2022;:1-12. [PMID: 35723075 DOI: 10.1080/17512433.2022.2075847] [Reference Citation Analysis]
3 Themistocleous SC, Yiallouris A, Tsioutis C, Zaravinos A, Johnson EO, Patrikios I. Clinical significance of P-class pumps in cancer. Oncol Lett 2021;22:658. [PMID: 34386080 DOI: 10.3892/ol.2021.12919] [Reference Citation Analysis]
4 Borgström A, Peinelt C, Stokłosa P. TRPM4 in Cancer-A New Potential Drug Target. Biomolecules 2021;11:229. [PMID: 33562811 DOI: 10.3390/biom11020229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
5 Van Campenhout R, Muyldermans S, Vinken M, Devoogdt N, De Groof TWM. Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor. Biomolecules 2021;11:63. [PMID: 33418902 DOI: 10.3390/biom11010063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Łapińska Z, Dębiński M, Szewczyk A, Choromańska A, Kulbacka J, Saczko J. Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer. Pharmaceutics 2020;13:E19. [PMID: 33374223 DOI: 10.3390/pharmaceutics13010019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]